Takashi Kijima

10PUBLICATIONS
65CO-AUTHORS
Epidemiological modellingMedical virologyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 06, 2026
Real-World Impact of Electronic Patient-Reported Outcomes on Early Intervention Among Older Patients With Lung Cancer: Prospective Cohort Study.

|Apr 01, 2026
Differential association of fluticasone furoate and budesonide with clinically detected COVID-19: a retrospective cohort study.

Masaki Tsunemi, Kozo Kuribayashi, Eiji Ishimura

|Jul 10, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata, Tadaaki Yamada, Yasuhiro Goto

|May 23, 2025
KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma.

Takashi Kijima, Terufumi Kato, Yasushi Goto

|May 19, 2025
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.

Shiho Goda, Tadaaki Yamada, Kenji Morimoto

|Oct 11, 2024
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi, Makoto Nishio, Hiroaki Akamatsu

Pageof 2

Frequent Collaborators

3 joint publications

Kozo Kuribayashi

3 joint publications

Tadaaki Yamada

2 joint publications

Nobukazu Fujimoto

2 joint publications

Yasushi Goto